ADC Therapeutics SA (ADCT)
Total Valuation
ADCT has a market cap or net worth of $567.63 million. The enterprise value is $261.41 million.
Market Cap | 567.63M |
Enterprise Value | 261.41M |
Important Dates
The latest earnings date was Monday, May 9, 2022, before market open.
Last Earnings Date | May 9, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
ADCT has 76.81 million shares outstanding. The number of shares has increased by 0.12% in one year.
Shares Outstanding | 76.81M |
Shares Change (YoY) | +0.12% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 52.35% |
Owned by Institutions (%) | 45.88% |
Float | 28.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.06 |
PB Ratio | 3.49 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.89, with a Debt / Equity ratio of 0.77.
Current Ratio | 6.89 |
Quick Ratio | 6.47 |
Debt / Equity | 0.77 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -102.70%, which is considered low. The company has a ROIC of -129.40%.
Return on Equity (ROE) | -102.70% |
Return on Assets (ROA) | -33.90% |
Return on Capital (ROIC) | -129.40% |
Revenue Per Employee | $257,740 |
Profits Per Employee | -$625,513 |
Employee Count | 312 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | -22.76M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.39% in the last 52 weeks. The beta is 1.85, so ADCT's price volatility has been higher than the market average.
Beta (1Y) | 1.85 |
52-Week Price Change | -67.39% |
50-Day Moving Average | 10.38 |
200-Day Moving Average | 16.19 |
Average Volume (30 Days) | 211,741 |
Short Selling Information
The latest short interest is 6.04 million, so 7.86% of the outstanding shares have been sold short.
Short Interest | 6.04M |
Short % of Shares Out | 7.86% |
Short % of Float | 20.92% |
Short Ratio (days to cover) | 36.80 |
Income Statement
In the last 12 months, ADCT had revenue of $80.42 million and -195.16 million in losses. Earnings per share was -$2.54.
Revenue | 80.42M |
Gross Profit | 78.49M |
Operating Income | -231.42M |
Pretax Income | -217.92M |
Net Income | -195.16M |
EBITDA | -244.83M |
EBIT | -247.47M |
Earnings Per Share (EPS) | -$2.54 |
Balance Sheet
The company has $430.87 million in cash and $124.65 million in debt, giving a net cash position of $306.22 million or $3.99 per share.
Cash & Cash Equivalents | 430.87M |
Total Debt | 124.65M |
Net Cash | 306.22M |
Net Cash Per Share | $3.99 |
Book Value | 162.67M |
Book Value Per Share | 2.12 |
Working Capital | 416.94M |
Cash Flow
In the last 12 months, operating cash flow was -$204.22 million and capital expenditures -$3.89 million, giving a free cash flow of -$208.11 million.
Operating Cash Flow | -204.22M |
Capital Expenditures | -3.89M |
Free Cash Flow | -208.11M |
FCF Per Share | n/a |
Margins
Gross margin is 97.61%, with operating and profit margins of -287.78% and -242.69%.
Gross Margin | 97.61% |
Operating Margin | -287.78% |
Pretax Margin | -270.99% |
Profit Margin | -242.69% |
EBITDA Margin | -304.45% |
EBIT Margin | -307.74% |
FCF Margin | -258.79% |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -34.38% |
FCF Yield | -36.66% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
The average price target for ADCT is $32.81, which is 343.98% higher than the current price. The consensus rating is "Buy".
Price Target | $32.81 |
Price Target Difference | 343.98% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |